Aska PharmaceuticalLtd. (4886.TSE) Q4 2024 Earnings

5NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
40
55
71
87

Details

Expected EPS
N/A
Actual EPS
48
Surprise EPS
48
Surprise Percent
+∞%

Description

Aska PharmaceuticalLtd. (4886.TSE) has reported earnings of 48 per share for Q4 2024.

0 Comments

Share your thoughts